Towards new tuberculosis drugs

The need for better drugs to treat tuberculosis has never been greater. Despite insufficient funding for discovery research, intensive efforts have been made to find and develop new lead compounds capable of reducing the duration of the present treatment known as DOTS (directly observed therapy short course), from 6 to under 4 months. This minireview describes the progress achieved during the last 5 years and highlights some of the successes without neglecting the problems.


Publié dans:
Biochemical Society Transactions, 35, 1321-1324
Présenté à:
Focus Topic at Life Sciences 2007 Conference, Glasgow, SCOTLAND, Jul 09-12, 2007
Année
2007
Mots-clefs:
Laboratoires:




 Notice créée le 2012-07-04, modifiée le 2018-09-13


Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)